Tocilizumab efficacy in a patient with positive anti-CCP chronic Lyme arthritis

Conclusion: Off label treatment by biologic disease modifying antirheumatic drugs can be considered in selected patients with severe antibiotic-resistant Lyme arthritis.C.

Source: North American Journal of Medical Sciences - April 7, 2016 Category: Journals (General) Authors: Julianna HirschItzhak RosnerDoron RimarLisa KalyMichael RozenbaumNina BoulmanGleb Slobodin Source Type: research